Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

IMW 2019 | An update on the genomic landscape of MM

Brian Walker, PhD, the University of Arkansas for Medical Sciences, Little Rock, AR, discusses the important aspects of myeloma genomics and how exome sequencing in large patient cohorts has revealed the prognostic significance of biallelic inactivation of TP53 and other mutations. This interview was held at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.